hUCB
CMUH101-IRB1-114
Phase 1 other completed
Quick answer
hUCB for Acute Ischemic Stroke is a Phase 1 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Acute Ischemic Stroke
- Phase
- Phase 1
- Modality
- other
- Status
- completed